The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference110 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020
2. Prognosis and treatment of complications associated with COVID-19: a systematic review and meta-analysis;Xie;Acta Materia Medica,2022
3. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study;Wu;Lancet,2020
4. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet,2020
5. Fight against novel coronavirus: a perspective of medicinal chemists;Amin;Eur. J. Med. Chem.,2020
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structural basis of main proteases of MERS-CoV bound to antineoplastic drug carmofur;Biochemical and Biophysical Research Communications;2024-11
2. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11
3. Are protein–ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?;Drug Discovery Today;2024-10
4. Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2;European Journal of Medicinal Chemistry;2024-10
5. A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis;Frontiers in Molecular Biosciences;2024-09-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3